EUVIMEDEUVIMED entdecken
Crossref

Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer

Ikuma Shioi, Hiroomi Ogawa, Ryozan Naito, Mizuki Endo, Nobuhiro Hosoi, Kohei Tateno, Shintaro Uchida, Arisa Yamaguchi, Takayoshi Watanabe, Nobuhiro Nakazawa, Yuta Shibasaki, Chika Komine und 8 weitere

Anticancer Research · 2024

DOI: 10.21873/anticanres.17114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Ikuma Shioi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Capecitabine, Oxaliplatin, Antineoplastic Combined Chemotherapy Protocols.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsCapecitabineOxaliplatinAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleMaleAgedMiddle AgedChemotherapy, AdjuvantRisk FactorsTreatment OutcomeRetrospective StudiesBody CompositionNeoplasm Recurrence, LocalAged, 80 and overAdult

Stichwörter der Autor:innen

CAPOXColorectal canceradjuvant therapybody composition factorearly dose reductionunderweight

Substanzen

CapecitabineOxaliplatin

Autor:innen und Institutionen

  • Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan hiroomio@gmail.com.

Zitieren

APA

Shioi, I., Ogawa, H., Naito, R., Endo, M., Hosoi, N., Tateno, K., Uchida, S., Yamaguchi, A., Watanabe, T., Nakazawa, N., Shibasaki, Y., Komine, C., Shiraishi, T., Osone, K., Okada, T., Sano, A., Sakai, M., Sohda, M., Shirabe, K., & Saeki, H. (2024). Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17114

Vancouver

Shioi I, Ogawa H, Naito R, Endo M, Hosoi N, Tateno K, et al. Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.17114

BibTeX
@article{Shioi2024,
  author = {Shioi, Ikuma and Ogawa, Hiroomi and Naito, Ryozan and Endo, Mizuki and Hosoi, Nobuhiro and Tateno, Kohei and Uchida, Shintaro and Yamaguchi, Arisa and Watanabe, Takayoshi and Nakazawa, Nobuhiro and Shibasaki, Yuta and Komine, Chika and Shiraishi, Takuya and Osone, Katsuya and Okada, Takuhisa and Sano, Akihiko and Sakai, Makoto and Sohda, Makoto and Shirabe, Ken and Saeki, Hiroshi},
  title = {Risks and Outcomes of Early Dose Reduction in Adjuvant CAPOX Therapy for Colorectal Cancer},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17114}
}
Kostenlos starten →